source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[biological replicate]	characteristics[sampling time]	assay name	Technology Type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	characteristics[technical replicate]	comment[cleavage agent details]	comment[cleavage agent details].1	comment[MS2 mass analyzer]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters].1	comment[modification parameters].2	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	1	-8W	20150701_qep1_lc7_phge_sa_plate3a_39_1	proteomic profiling by mass spectrometry	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	2	0W	20150701_qep1_lc7_phge_sa_plate3a_39_2	proteomic profiling by mass spectrometry	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	3	4W	20150701_qep1_lc7_phge_sa_plate3a_39_3	proteomic profiling by mass spectrometry	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	4	13W	20150701_qep1_lc7_phge_sa_plate3a_39_4	proteomic profiling by mass spectrometry	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	5	26W	20150701_qep1_lc7_phge_sa_plate3a_39_5	proteomic profiling by mass spectrometry	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	6	39W	20150701_qep1_lc7_phge_sa_plate3a_39_6	proteomic profiling by mass spectrometry	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	7	52W	20150701_qep1_lc7_phge_sa_plate3a_39_7	proteomic profiling by mass spectrometry	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	8	0W	20150725_qep1_lc7_phge_sa_plate3b_39_2	proteomic profiling by mass spectrometry	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	9	4W	20150725_qep1_lc7_phge_sa_plate3b_39_3	proteomic profiling by mass spectrometry	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	10	13W	20150725_qep1_lc7_phge_sa_plate3b_39_4	proteomic profiling by mass spectrometry	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	11	26W	20150725_qep1_lc7_phge_sa_plate3b_39_5	proteomic profiling by mass spectrometry	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	12	39W	20150725_qep1_lc7_phge_sa_plate3b_39_6	proteomic profiling by mass spectrometry	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	13	52W	20150725_qep1_lc7_phge_sa_plate3b_39_7	proteomic profiling by mass spectrometry	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	14	-8W	20150818_qep1_lc7_phge_sa_plate3c_39_1	proteomic profiling by mass spectrometry	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	15	0W	20150818_qep1_lc7_phge_sa_plate3c_39_2	proteomic profiling by mass spectrometry	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	16	4W	20150818_qep1_lc7_phge_sa_plate3c_39_3	proteomic profiling by mass spectrometry	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	17	13W	20150818_qep1_lc7_phge_sa_plate3c_39_4	proteomic profiling by mass spectrometry	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	18	26W	20150818_qep1_lc7_phge_sa_plate3c_39_5	proteomic profiling by mass spectrometry	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	19	39W	20150818_qep1_lc7_phge_sa_plate3c_39_6	proteomic profiling by mass spectrometry	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	20	52W	20150818_qep1_lc7_phge_sa_plate3c_39_7	proteomic profiling by mass spectrometry	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	21	-8W	20150912_qep1_lc7_phge_sa_plate3d_39_1	proteomic profiling by mass spectrometry	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	22	0W	20150912_qep1_lc7_phge_sa_plate3d_39_2	proteomic profiling by mass spectrometry	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	23	4W	20150912_qep1_lc7_phge_sa_plate3d_39_3	proteomic profiling by mass spectrometry	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	24	26W	20150912_qep1_lc7_phge_sa_plate3d_39_5	proteomic profiling by mass spectrometry	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	25	39W	20150912_qep1_lc7_phge_sa_plate3d_39_6	proteomic profiling by mass spectrometry	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	26	52W	20150912_qep1_lc7_phge_sa_plate3d_39_7	proteomic profiling by mass spectrometry	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	27	-8W	20150917_qep1_lc7_phge_sa_plate3b_39_1	proteomic profiling by mass spectrometry	20150917_QEp1_LC7_PhGe_SA_Plate3B_39_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_39_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	28	13W	20150917_qep1_lc7_phge_sa_plate3d_39_4	proteomic profiling by mass spectrometry	20150917_QEp1_LC7_PhGe_SA_Plate3D_39_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3D_39_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
